H.B. Fuller (NYSE:FUL) Price Target Cut to $50.00 by Analysts at JPMorgan Chase & Co.

H.B. Fuller (NYSE:FUL) had its price objective reduced by JPMorgan Chase & Co. from $60.00 to $50.00 in a research report sent to investors on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the specialty chemicals company’s stock.

Several other research analysts have also issued reports on the stock. Citigroup cut their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Seaport Res Ptn downgraded H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft dropped their price target on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a research note on Wednesday, January 22nd. Finally, Vertical Research cut H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $70.00.

H.B. Fuller Stock Performance

FUL stock opened at $54.76 on Friday. The firm has a market cap of $2.97 billion, a PE ratio of 23.70, a price-to-earnings-growth ratio of 1.13 and a beta of 1.41. The company has a current ratio of 1.81, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10. The stock has a 50-day moving average price of $58.31 and a 200-day moving average price of $68.75. H.B. Fuller has a 1-year low of $52.59 and a 1-year high of $87.67.

H.B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.05. The business had revenue of $788.66 million during the quarter, compared to the consensus estimate of $769.55 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.67 earnings per share. As a group, equities research analysts expect that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, February 20th. Investors of record on Thursday, February 6th were given a dividend of $0.2225 per share. The ex-dividend date of this dividend was Thursday, February 6th. This represents a $0.89 annualized dividend and a dividend yield of 1.63%. H.B. Fuller’s payout ratio is 38.53%.

Institutional Investors Weigh In On H.B. Fuller

Institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC raised its holdings in shares of H.B. Fuller by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares during the last quarter. Lord Abbett & CO. LLC grew its position in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock worth $37,448,000 after buying an additional 81,558 shares in the last quarter. Kennedy Capital Management LLC boosted its stake in shares of H.B. Fuller by 13.4% in the 4th quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock worth $8,630,000 after buying an additional 15,100 shares during the last quarter. Finally, MetLife Investment Management LLC grew its holdings in shares of H.B. Fuller by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock valued at $2,231,000 after acquiring an additional 1,472 shares in the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.